ID   AP180_RAT               Reviewed;         915 AA.
AC   Q05140;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   08-NOV-2023, entry version 166.
DE   RecName: Full=Clathrin coat assembly protein AP180;
DE   AltName: Full=91 kDa synaptosomal-associated protein;
DE   AltName: Full=Clathrin coat-associated protein AP180;
GN   Name=Snap91;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=8440257; DOI=10.1002/j.1460-2075.1993.tb05700.x;
RA   Morris S.A., Schroeder S., Plessmann U., Weber K., Ungewickell E.;
RT   "Clathrin assembly protein AP180: primary structure, domain organization
RT   and identification of a clathrin binding site.";
RL   EMBO J. 12:667-675(1993).
RN   [2]
RP   PROTEIN SEQUENCE OF 25-39 AND 247-252 (ISOFORMS 1/2), AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [3]
RP   PROTEIN SEQUENCE OF 305-320 (ISOFORMS 1/2), PROTEIN SEQUENCE OF 598-649
RP   (ISOFORM 2), GLYCOSYLATION AT THR-310, PHOSPHORYLATION AT SER-306; SER-313;
RP   SER-600; SER-640 AND SER-646, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=21500857; DOI=10.1021/pr1011153;
RA   Graham M.E., Thaysen-Andersen M., Bache N., Craft G.E., Larsen M.R.,
RA   Packer N.H., Robinson P.J.;
RT   "A novel post-translational modification in nerve terminals: O-linked N-
RT   acetylglucosamine phosphorylation.";
RL   J. Proteome Res. 10:2725-2733(2011).
RN   [4]
RP   INTERACTION WITH AP2A2.
RX   PubMed=10380931; DOI=10.1016/s0092-8674(00)80791-6;
RA   Owen D.J., Vallis Y., Noble M.E.M., Hunter J.B., Dafforn T.R., Evans P.R.,
RA   McMahon H.T.;
RT   "A structural explanation for the binding of multiple ligands by the alpha-
RT   adaptin appendage domain.";
RL   Cell 97:805-815(1999).
RN   [5]
RP   INTERACTION WITH AP2A2.
RX   PubMed=10430869; DOI=10.1073/pnas.96.16.8907;
RA   Traub L.M., Downs M.A., Westrich J.L., Fremont D.H.;
RT   "Crystal structure of the alpha appendage of AP-2 reveals a recruitment
RT   platform for clathrin-coat assembly.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:8907-8912(1999).
RN   [6]
RP   INTERACTION WITH AP2B1.
RX   PubMed=10944104; DOI=10.1093/emboj/19.16.4216;
RA   Owen D.J., Vallis Y., Pearse B.M.F., McMahon H.T., Evans P.R.;
RT   "The structure and function of the beta 2-adaptin appendage domain.";
RL   EMBO J. 19:4216-4227(2000).
RN   [7]
RP   INTERACTION WITH AP2B1.
RX   PubMed=16516836; DOI=10.1016/j.devcel.2006.01.016;
RA   Edeling M.A., Mishra S.K., Keyel P.A., Steinhauser A.L., Collins B.M.,
RA   Roth R., Heuser J.E., Owen D.J., Traub L.M.;
RT   "Molecular switches involving the AP-2 beta2 appendage regulate endocytic
RT   cargo selection and clathrin coat assembly.";
RL   Dev. Cell 10:329-342(2006).
RN   [8]
RP   INTERACTION WITH AP2B1.
RX   PubMed=16903783; DOI=10.1371/journal.pbio.0040262;
RA   Schmid E.M., Ford M.G.J., Burtey A., Praefcke G.J.K., Peak-Chew S.-Y.,
RA   Mills I.G., Benmerah A., McMahon H.T.;
RT   "Role of the AP2 beta-appendage hub in recruiting partners for clathrin-
RT   coated vesicle assembly.";
RL   PLoS Biol. 4:E262-E262(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296; SER-300; SER-313;
RP   SER-594 AND SER-775, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-600 AND
RP   SER-627 (ISOFORM 2), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Adaptins are components of the adapter complexes which link
CC       clathrin to receptors in coated vesicles. Clathrin-associated protein
CC       complexes are believed to interact with the cytoplasmic tails of
CC       membrane proteins, leading to their selection and concentration.
CC       Binding of AP180 to clathrin triskelia induces their assembly into 60-
CC       70 nm coats.
CC   -!- SUBUNIT: Binds AP2A2. Interacts with AP2B1; clathrin competes with
CC       SNAP91. {ECO:0000269|PubMed:10380931, ECO:0000269|PubMed:10430869,
CC       ECO:0000269|PubMed:10944104, ECO:0000269|PubMed:16516836,
CC       ECO:0000269|PubMed:16903783}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane. Membrane, coated pit; Peripheral
CC       membrane protein; Cytoplasmic side. Note=Component of the coat
CC       surrounding the cytoplasmic face of coated vesicles in the plasma
CC       membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q05140-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q05140-2; Sequence=VSP_000173;
CC   -!- DOMAIN: Possesses a three domain structure: the N-terminal 300 residues
CC       harbor a clathrin binding site, an acidic middle domain 450 residues,
CC       interrupted by an Ala-rich segment, and the C-terminal domain (166
CC       residues).
CC   -!- PTM: Thr-310 can be modified by the addition of N-acetylglucosamine
CC       which can be further phosphorylated. The form with phosphorylated O-
CC       linked N-acetylglucosamine is predominant in brain synaptosomes. There
CC       is no evidence for direct Thr-310 phosphorylation (PubMed:21500857).
CC       {ECO:0000269|PubMed:21500857}.
CC   -!- SIMILARITY: Belongs to the PICALM/SNAP91 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X68877; CAA48748.1; -; mRNA.
DR   EMBL; X68878; CAA48749.1; -; mRNA.
DR   PIR; S36326; S36326.
DR   PIR; S36327; S36327.
DR   RefSeq; NP_113916.1; NM_031728.1.
DR   AlphaFoldDB; Q05140; -.
DR   BMRB; Q05140; -.
DR   SMR; Q05140; -.
DR   BioGRID; 249290; 10.
DR   CORUM; Q05140; -.
DR   ELM; Q05140; -.
DR   IntAct; Q05140; 6.
DR   MINT; Q05140; -.
DR   STRING; 10116.ENSRNOP00000030821; -.
DR   GlyCosmos; Q05140; 1 site, No reported glycans.
DR   GlyGen; Q05140; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q05140; -.
DR   PhosphoSitePlus; Q05140; -.
DR   SwissPalm; Q05140; -.
DR   jPOST; Q05140; -.
DR   PaxDb; 10116-ENSRNOP00000030821; -.
DR   GeneID; 65178; -.
DR   KEGG; rno:65178; -.
DR   UCSC; RGD:69276; rat. [Q05140-1]
DR   AGR; RGD:69276; -.
DR   CTD; 9892; -.
DR   RGD; 69276; Snap91.
DR   eggNOG; KOG0251; Eukaryota.
DR   InParanoid; Q05140; -.
DR   OrthoDB; 3667239at2759; -.
DR   PhylomeDB; Q05140; -.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   PRO; PR:Q05140; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0005905; C:clathrin-coated pit; IBA:GO_Central.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:CAFA.
DR   GO; GO:0031313; C:extrinsic component of endosome membrane; ISO:RGD.
DR   GO; GO:0098894; C:extrinsic component of presynaptic endocytic zone membrane; IDA:SynGO.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0014069; C:postsynaptic density; IDA:BHF-UCL.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:BHF-UCL.
DR   GO; GO:0048787; C:presynaptic active zone membrane; IDA:RGD.
DR   GO; GO:0098833; C:presynaptic endocytic zone; ISO:RGD.
DR   GO; GO:0098830; C:presynaptic endosome; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:BHF-UCL.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:BHF-UCL.
DR   GO; GO:0043195; C:terminal bouton; HDA:ParkinsonsUK-UCL.
DR   GO; GO:0005545; F:1-phosphatidylinositol binding; ISO:RGD.
DR   GO; GO:0035615; F:clathrin adaptor activity; IMP:CAFA.
DR   GO; GO:0030276; F:clathrin binding; IPI:DisProt.
DR   GO; GO:0032050; F:clathrin heavy chain binding; IPI:CAFA.
DR   GO; GO:0000822; F:inositol hexakisphosphate binding; IDA:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:RGD.
DR   GO; GO:0043274; F:phospholipase binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0042169; F:SH2 domain binding; IPI:RGD.
DR   GO; GO:0000149; F:SNARE binding; IPI:RGD.
DR   GO; GO:0007409; P:axonogenesis; IMP:BHF-UCL.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0048268; P:clathrin coat assembly; IDA:DisProt.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; IBA:GO_Central.
DR   GO; GO:0007163; P:establishment or maintenance of cell polarity; IMP:BHF-UCL.
DR   GO; GO:0051899; P:membrane depolarization; IEP:RGD.
DR   GO; GO:0048666; P:neuron development; IMP:RGD.
DR   GO; GO:0007269; P:neurotransmitter secretion; ISO:RGD.
DR   GO; GO:0050772; P:positive regulation of axonogenesis; IMP:RGD.
DR   GO; GO:1905445; P:positive regulation of clathrin coat assembly; IMP:CAFA.
DR   GO; GO:2000809; P:positive regulation of synaptic vesicle clustering; IMP:RGD.
DR   GO; GO:1900244; P:positive regulation of synaptic vesicle endocytosis; IMP:RGD.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:2000369; P:regulation of clathrin-dependent endocytosis; ISO:RGD.
DR   GO; GO:0030100; P:regulation of endocytosis; IMP:BHF-UCL.
DR   GO; GO:0051223; P:regulation of protein transport; IMP:BHF-UCL.
DR   GO; GO:1900242; P:regulation of synaptic vesicle endocytosis; IMP:RGD.
DR   GO; GO:2000331; P:regulation of terminal button organization; IMP:RGD.
DR   GO; GO:0016185; P:synaptic vesicle budding from presynaptic endocytic zone membrane; ISO:RGD.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; IDA:SynGO.
DR   CDD; cd16985; ANTH_N_AP180; 1.
DR   DisProt; DP00225; -.
DR   Gene3D; 1.25.40.90; -; 1.
DR   Gene3D; 1.20.58.150; ANTH domain; 1.
DR   InterPro; IPR011417; ANTH_dom.
DR   InterPro; IPR014712; ANTH_dom_sf.
DR   InterPro; IPR045192; AP180-like.
DR   InterPro; IPR013809; ENTH.
DR   InterPro; IPR008942; ENTH_VHS.
DR   PANTHER; PTHR22951; CLATHRIN ASSEMBLY PROTEIN; 1.
DR   PANTHER; PTHR22951:SF4; CLATHRIN COAT ASSEMBLY PROTEIN AP180; 1.
DR   Pfam; PF07651; ANTH; 1.
DR   SMART; SM00273; ENTH; 1.
DR   SUPFAM; SSF48464; ENTH/VHS domain; 1.
DR   SUPFAM; SSF89009; GAT-like domain; 1.
DR   PROSITE; PS50942; ENTH; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Coated pit; Direct protein sequencing;
KW   Glycoprotein; Membrane; Methylation; Phosphoprotein; Protein transport;
KW   Reference proteome; Transport.
FT   CHAIN           1..915
FT                   /note="Clathrin coat assembly protein AP180"
FT                   /id="PRO_0000193866"
FT   DOMAIN          14..145
FT                   /note="ENTH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00243"
FT   REGION          285..326
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          391..425
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          497..522
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          720..765
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          817..855
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          875..915
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        285..323
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        720..734
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         296
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         300
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         306
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21500857"
FT   MOD_RES         313
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21500857,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         317
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61548"
FT   MOD_RES         594
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         600
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21500857"
FT   MOD_RES         640
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21500857"
FT   MOD_RES         646
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21500857"
FT   MOD_RES         775
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         873
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q61548"
FT   MOD_RES         873
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q61548"
FT   CARBOHYD        310
FT                   /note="O-linked (GlcNAc) threonine"
FT                   /evidence="ECO:0000269|PubMed:21500857"
FT   VAR_SEQ         614..632
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8440257"
FT                   /id="VSP_000173"
FT   MOD_RES         Q05140-2:600
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         Q05140-2:627
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   915 AA;  93519 MW;  32EC1B38EC5DF8C0 CRC64;
     MSGQTLTDRI AAAQYSVTGS AVARAVCKAT THEVMGPKKK HLDYLIQATN ETNVNIPQMA
     DTLFERATNS SWVVVFKALV TTHHLMVHGN ERFIQYLASR NTLFNLSNFL DKSGSHGYDM
     STFIRRYSRY LNEKAFSYRQ MAFDFARVKK GADGVMRTMV PEKLLKSMPI LQGQIDALLE
     FDVHPNELTN GVINAAFMLL FKDLIKLFAC YNDGVINLLE KFFEMKKGQC KDALEIYKRF
     LTRMTRVSEF LKVADEVGID KGDIPDLTQA PSSLMETLEQ HLNTLEGKKP GNNEGSGAPS
     PLSKSSPATT VTSPNSTPAK TIDTSPPVDI FATASAAAPV SSAKPSSDLL DLQPDFSGAR
     AGAAAPVPPP TGGATAWGDL LGEDSLAALS SVPSEAPISD PFAPEPSPPT TTTEPASASA
     SATTAVTAAT TEVDLFGDAF AASPGEAPAA SEGATAPATP APVAAALDAC SGNDPFAPSE
     GSAEAAPELD LFAMKPPETS APVVTPTAST APPVPATAPS PAPTAVAATA ATTTAAAAAT
     TTATTSAAAA TTAAAPPALD IFGDLFDSAP EVAAASKPDV APSIDLFGTD AFSSPPRGAS
     PVPESSLTAD LLSGSGFHCA EDDRHVPLFF TAVDAFAAPS PASTASPAKA ESSGVIDLFG
     DAFGSSASET QPAPQAVSSS SASADLLAGF GGSFMAPSTT PVTPAQNNLL QPNFEAAFGT
     TPSTSSSSSF DPSGDLLMPT MAPSGQPAPV SMVPPSPAMS ASKGLGSDLD SSLASLVGNL
     GISGTTSKKG DLQWNAGEKK LTGGANWQPK VTPATWSAGV PPQGTVPPTS SVPPGAGAPS
     VGQPGAGYGM PPAGTGMTMM PQQPVMFAQP MMRPPFGAAA VPGTQLSPSP TPATQSPKKP
     PAKDPLADLN IKDFL
//
